News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
About
Partnerships

|Articles|August 9, 2011

A Study on Septic Abortion at a Tertiary Hospital

Author(s)Arati Patnaik, MD, Surendra Nath Panda, MS

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related Content

FDA grants 510(k) clearance to Roche's cobas BV/CV assay

FDA grants 510(k) clearance to Roche's cobas BV/CV assay

ByJoshua Fitch, Senior Editor

July 24th 2026

A discussion of STI rates, barriers, and home screenings with Damian Alagia III, MD

A discussion of STI rates, barriers, and home screenings with Damian Alagia III, MD

ByDamian Alagia, III, MD, MS, MBA, FACS,

July 20th 2026

National strategy calls for $20B investment to close women's health gap | Image credit: stock.adobe.com

National strategy calls for $20B investment to close women's health gap

ByJoshua Fitch, Senior Editor

July 15th 2026

Kate McLean, MD, MPH, on how bacterial vaginosis subtypes may validate symptoms, guide treatment

Kate McLean, MD, MPH, on how bacterial vaginosis subtypes may validate symptoms, guide treatment

ByKate McLean MD, MPH, FACOG

July 13th 2026

At-home pelvic ultrasound feasible, preferred over in-clinic care | stock.adobe.com.

At-home pelvic ultrasound feasible, preferred over in-clinic care

ByJoshua Fitch, Senior Editor

July 7th 2026

Latest CME

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Case-based Simulation

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Rachel N. Grisham, MD

Trending on Contemporary OB/GYN

Updated: CMS proposed G-codes for obstetric billing draw concern from ACOG amid coding transition

Natural Cycles receives FDA clearance for AI-powered fertility algorithm

FDA grants 510(k) clearance to Roche's cobas BV/CV assay

Late preterm hypoglycemia not tied to neurodevelopment at age 6

CMS' obstetric G-codes draw concern, HIV screening recommendation strengthened, Roche's BV/CV assay clearance